wpadmin

MassTech Signs Co-Marketing Agreement With Applied Biosystems/MDS SCIEX

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry, and Applied Biosystems/MDS SCIEX, a joint-venture between Applied Biosystems Group (NYSE: ABI) an Applera Corporation Business, and MDS Inc. (TSE:MDS; NYSE: MDZ), today announced that it has signed an agreement to market the MassTech AP/MALDI system as a front end ion source for the AB/MDS SCIEX 4000 Q TRAP® LC/MS/MS. The collaboration brings MALDI capabilities to the 4000 Q TRAP® LC/MS/MS platform to facilitate metabolite identification and post-translational modification identification.…

Read More

MassTech To Develop an Atmospheric Pressure MALDI Source (AP/MALDI) for the 4000 Q TRAP® LC/MS/MS system of Applied Biosystems/MDS SCIEX

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry today announced that it will develop an Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization (AP/MALDI) ion source for the 4000 Q TRAP® LC/MS/MS System with the assistance of Applied Biosystems/MDS SCIEX. Applied Biosystems/MDS SCIEX, the manufacturer of the 4000 Q TRAP® system, is a joint venture between Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and MDS Inc. (TSE:MDS; NYSE:MDZ). The 4000 Q TRAP® system is used during most stages of drug…

Read More